Screener
Agios Pharmaceuticals AGIO Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's enterprise value?
- Agios Pharmaceuticals (AGIO) reported enterprise value of $2.14B in Q2 2026.
- How has Agios Pharmaceuticals's enterprise value changed year-over-year?
- Agios Pharmaceuticals's enterprise value increased by 12.4% year-over-year, from $1.9B to $2.14B.
- What is the long-term trend for Agios Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's enterprise value has grown at a -8.0% compound annual growth rate (CAGR), from $2.33B to $1.54B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Agios Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude